Death from differentiated thyroid carcinoma: Retrospective study of a 40-year investigation

Cancer Biotherapy and Radiopharmaceuticals

Volumn 17, Issue 5, 2002, Pages 507-514

  Ronga, Giuseppe ^a   Filesi, Mauro ^a   Montesano, Teresa ^a   Melacrinis, Francesca Fiore ^a   Di Nicola, Angelo ^a   Ventroni, Guido ^a   Antonaci, Alfredo ^a   Vestri, Anna R ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Death; Local recurrence; Radioiodine therapy; Thyroid carcinoma

Indexed keywords

IODINE 131; RADIOACTIVE IODINE;

ADULT; ARTICLE; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CAUSE OF DEATH; DRUG MEGADOSE; DRUG UPTAKE; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THYROID CANCER; THYROID CARCINOMA; THYROIDECTOMY; TREATMENT OUTCOME; TUMOR GROWTH; WHOLE BODY SCANNER;

ADULT; AGE FACTORS; AGED; BONE NEOPLASMS; CARCINOMA; FEMALE; HUMANS; IODINE RADIOISOTOPES; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; THYROID NEOPLASMS; TIME FACTORS;

EID: 0036029793     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/108497802760804736     Document Type: Article

References (32)

1. 131I therapy of thyroid cancer patients. Q J Nucl Med 1999;43:324.
2. Franceschi S, La Vecchia C. Thyroid cancer. Cancer Surv 1994;19:393.
3. Grant CS, Hay ID, Gough IR, Bergstralh EJ, Goellner JR, McConahey WM. Local recurrence in papillary thyroid carcinoma: Is extent of surgical resection important? Surgey 1988;104:954.
4. Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical treatment and medical therapy on papillary and follicular thyroid cancer. Am J Med 1994;97:418.
5. Hay ID, Grant CS, Talor WF, McConahey WM. Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: A retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery 1987;102:1088.
6. Cady B, Rossi R. An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery 1988;104:947.
7. Moreno-Egea A, Rodriguez-Gonzalez JM, Sala-Perez J, Soria-Cogollos T, Parrilla-Paricio P. Multivariate analysis of histopathological features as prognostic factors in patients with papillary thyroid carcinoma. Br J Surg 1995;82:1092.
8. Treseler PA, Clark OH. Prognostic factors in thyroid carcinoma. Surg Oncol Clin N Am 1997;6:555.
9. Staunton MD. Thyroid cancer: A multivariate analysis on influence of treatment on long-term survival. Eur J Surg Oncol 1994;20:613.
10. Shah JP, Loree TR, Dharker D, Strong EW, Begg C, Vlanis V. Prognostic factors in differentiated thyroid carcinoma of the thyroid gland. Am J Surg 1992;164:658.
11. Tubiana M, Schlumberger M, Rougier P, La Planche A, Benhamou E, Gardet P, Caillou B, Travagli JP, Parmentier C. Long-term results and prognostic factors in patients with differentiated thyroid carcinoma. Cancer 1985;55:794.
12. Mazzaferri EL. Treating differentiated thyroid carcinoma: Where do we draw the line? Mayo Clin Proc 1991;66:105.
13. Gilliland FD, Hunt WC, Morris DM, Key CR. Prognostic factors for thyroid carcinoma. Br J Surg 1997;79:564.
14. Tovi F, Goldstein J. Locally aggressive differentiated thyroid carcinoma. J Surg Oncol 1985;19:99.
15. Asakawa H, Kobayashi T, Komoike Y, Tamaki Y, Matsuzawa Y, Monden M. Prognostic factors in patients with recurrent differentiated thyroid carcinoma. J Surg Oncol 1997;64:202.
16. Nussbaum M, Bukachevsky R. Thyroid carcinoma presenting as a regional neck mass. Head Neck 1990;12:114.
17. Hamby LS, McGrath PC, Schwartz RW, Sloan DA, Simpson WG, Kenady DE. Management of local recurrence in well-differentiated thyroid carcinoma. J Surg Res 1992;52:113.
18. Robbins J, Merino MJ, Boice JD Jr, Ron E, Ain KB, Alexander HR, Norton JA, Reynolds J. Thyroid cancer: A lethal endocrine neoplasm. Ann Intern Med 1991;115:133.
19. Wanebo H, Coburn M, Teates D, Cole B. Total thyroidectomy does not enhance disease control or survival even in high-risk patients with differentiated thyroid cancer. Ann Surg 1998;227:912.
20. Cunningham MP, Duda RB, Recant W, Chmiel JS, Sylvester JA, Fremgen A. Survival discriminants for differentiated thyroid cancer. Am J Surg 1990;160:344.
21. Sherman SI, Tielens ET, Sostre S, Wharam MD Jr, Ladenson PW. Clinical utility of post-treatment radioiodine scans in the management of patients with thyroid carcinoma. J Clin Endocr Metab 1994;78:629.
22. Spies WG, Wojtowicz CH, Spies SM, Shah AY, Zimmer AM. Value of post-therapy whole body I-131 imaging in the evaluation of patients with thyroid carcinoma having undergone high dose 1-131 therapy. Clin Nucl Med 1989;14:793.
23. Schlumberger M, Travagli JP, Fragu P, Gardet P, Lumbroso J, Parmentier C. Follow-up of patients with differentiated thyroid carcinoma. Experience at Institut Gustave Roussy, Villejuif. Eur J Cancer Clin Oncol 1988;24:345.
24. Schlumberger M. Papillary and follicular thyroid carcinoma. N Engl J Med 1998;338:297.
25. Filesi M, Signore A, Ventroni G, Melacrinis Fiore F, Ronga G. Role of initial iodine-131 whole-body scan and serum thyroglobulin in differentiated thyroid carcinoma metastases. J Nucl Med 1998;39:1542.
26. De Groot LJ, Kaplan E, McCormick M, Straus FH. Natural history, treatment and course of papillary thyroid carcinoma. J Clin Endocr Metab 1990;71:414.
27. Bakheet S, Hammami MM. False positive thyroid cancer metastasis on whole body radioiodine scanning due to retained radioactivity in the oesophagus. Eur J Nucl Med 1993;20:415.
28. Kolla SI, Alazraki NP, Watts NB. Sialadenitis mimicking metastatic thyroid carcinoma. Clin Nucl Med 1989;14:564.
29. Schlumberger M, De Vathaire F, Ceccarelli C, Delisle MJ, Francese C, Couette JE, Pinchera A, Parmentier C. Exposure to radioactive iodine-131 for scintigraphy or therapy does not preclude pregnancy in thyroid cancer patients. J Nucl Med 1996;37:606.
30. Filetti S, Bidart JM, Arturi F, Caillou B, Russo D, Schlumberger M. Sodium/iodide symporter: A key transport system in thyroid cancer cell metabolism. Eur J Endocrinol 1999;141:443.
31. 131I uptake in recurrent lesions of differentiated thyroid carcinoma. Eur J Nucl Med 2001;28:639.
32. Simpson WJ, McKinney SE, Carruthers JS, Gospodarowicz MK, Sutcliffes SB, Panzarella T. Papillary and follicular thyroid cancer. Prognostic factors in 1578 patients. Am J Med 1987;83:479.